AbbVie (ABBV) is a publicly traded Healthcare sector company. As of July 21, 2026, ABBV trades at $253.45 with a market cap of $449.63B and a P/E ratio of 124.75. ABBV moved -0.44% today. Year to date, ABBV is +10.29%; over the trailing twelve months it is +33.88%. Its 52-week range spans $164.39 to $261.64. Analyst consensus is strong buy with an average price target of $273.25. Rallies surfaces ABBV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ABBV insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $253.45 |
| Market Cap | $449.63B |
| P/E Ratio | 124.75 |
| EPS | $2.03 |
| Dividend Yield | 1.73% |
| 52-Week High | $261.64 |
| 52-Week Low | $164.39 |
| Volume | 3.09M |
| Avg Volume | 0 |
| Revenue (TTM) | $62.82B |
| Net Income | $3.64B |
| Gross Margin | 70.68% |
22 analysts cover ABBV: 0 strong buy, 18 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $273.25.